We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Sensus Healthcare, Inc. (SRTS) Rises As Market Takes a Dip: Key Facts
Read MoreHide Full Article
The most recent trading session ended with Sensus Healthcare, Inc. (SRTS - Free Report) standing at $4.69, reflecting a +1.08% shift from the previouse trading day's closing. The stock's change was more than the S&P 500's daily loss of 0.33%. Meanwhile, the Dow lost 0.37%, and the Nasdaq, a tech-heavy index, lost 0.53%.
Prior to today's trading, shares of the company had lost 5.11% over the past month. This has lagged the Medical sector's loss of 3.24% and the S&P 500's loss of 4.03% in that time.
The upcoming earnings release of Sensus Healthcare, Inc. will be of great interest to investors. The company is predicted to post an EPS of $0.08, indicating a 42.86% decline compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $7.93 million, indicating a 25.61% downward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.33 per share and revenue of $41.82 million. These totals would mark changes of -19.51% and +0.03%, respectively, from last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Sensus Healthcare, Inc. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Sensus Healthcare, Inc. is currently a Zacks Rank #4 (Sell).
In terms of valuation, Sensus Healthcare, Inc. is presently being traded at a Forward P/E ratio of 14.28. This represents a discount compared to its industry's average Forward P/E of 27.74.
The Medical - Instruments industry is part of the Medical sector. With its current Zacks Industry Rank of 71, this industry ranks in the top 29% of all industries, numbering over 250.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Sensus Healthcare, Inc. (SRTS) Rises As Market Takes a Dip: Key Facts
The most recent trading session ended with Sensus Healthcare, Inc. (SRTS - Free Report) standing at $4.69, reflecting a +1.08% shift from the previouse trading day's closing. The stock's change was more than the S&P 500's daily loss of 0.33%. Meanwhile, the Dow lost 0.37%, and the Nasdaq, a tech-heavy index, lost 0.53%.
Prior to today's trading, shares of the company had lost 5.11% over the past month. This has lagged the Medical sector's loss of 3.24% and the S&P 500's loss of 4.03% in that time.
The upcoming earnings release of Sensus Healthcare, Inc. will be of great interest to investors. The company is predicted to post an EPS of $0.08, indicating a 42.86% decline compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $7.93 million, indicating a 25.61% downward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.33 per share and revenue of $41.82 million. These totals would mark changes of -19.51% and +0.03%, respectively, from last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Sensus Healthcare, Inc. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Sensus Healthcare, Inc. is currently a Zacks Rank #4 (Sell).
In terms of valuation, Sensus Healthcare, Inc. is presently being traded at a Forward P/E ratio of 14.28. This represents a discount compared to its industry's average Forward P/E of 27.74.
The Medical - Instruments industry is part of the Medical sector. With its current Zacks Industry Rank of 71, this industry ranks in the top 29% of all industries, numbering over 250.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.